News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
853,008 Results
Type
Article (86888)
Company Profile (704)
Press Release (765415)
Multimedia
Podcasts (147)
Webinars (19)
Section
Business (232823)
Career Advice (4133)
Deals (39763)
Drug Delivery (129)
Drug Development (91111)
Employer Resources (198)
FDA (18190)
Job Trends (17364)
News (396857)
Policy (39826)
Tag
Academia (3002)
Academic (2)
Accelerated approval (12)
Adcomms (32)
Allergies (106)
Alliances (56975)
ALS (120)
Alzheimer's disease (1572)
Antibody-drug conjugate (ADC) (188)
Approvals (18141)
Artificial intelligence (401)
Autoimmune disease (37)
Automation (19)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (137)
Biotechnology (482)
Bladder cancer (100)
Brain cancer (41)
Breast cancer (392)
Cancer (3103)
Cardiovascular disease (249)
Career advice (3541)
Career pathing (34)
CAR-T (209)
CDC (41)
Cell therapy (576)
Cervical cancer (24)
Clinical research (74331)
Collaboration (1114)
Company closure (3)
Compensation (715)
Complete response letters (34)
COVID-19 (2905)
CRISPR (68)
C-suite (359)
Cystic fibrosis (122)
Data (3104)
Decentralized trials (2)
Denatured (51)
Depression (77)
Diabetes (380)
Diagnostics (6982)
Digital health (26)
Diversity (10)
Diversity, equity & inclusion (49)
Drug discovery (183)
Drug pricing (152)
Drug shortages (36)
Duchenne muscular dystrophy (138)
Earnings (97532)
Editorial (48)
Employer branding (25)
Employer resources (169)
Events (131481)
Executive appointments (910)
FDA (19940)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1020)
Gene editing (149)
Generative AI (40)
Gene therapy (439)
GLP-1 (937)
Government (5264)
Grass and pollen (6)
Guidances (181)
Healthcare (20917)
HIV (45)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (185)
Immuno-oncology (11)
Indications (40)
Infectious disease (3102)
Inflammatory bowel disease (165)
Inflation Reduction Act (13)
Influenza (71)
Intellectual property (125)
Interviews (813)
IPO (17906)
IRA (55)
Job creations (5194)
Job search strategy (2863)
Kidney cancer (15)
Labor market (56)
Layoffs (593)
Leadership (26)
Legal (10137)
Liver cancer (85)
Longevity (12)
Lung cancer (435)
Lymphoma (216)
Machine learning (11)
Management (65)
Manufacturing (448)
MASH (100)
Medical device (14733)
Medtech (14738)
Mergers & acquisitions (22586)
Metabolic disorders (969)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (145)
Neuropsychiatric disorders (42)
Neuroscience (2332)
NextGen: Class of 2025 (7687)
Non-profit (5090)
Now hiring (48)
Obesity (496)
Opinion (291)
Ovarian cancer (104)
Pain (122)
Pancreatic cancer (126)
Parkinson's disease (201)
Partnered (25)
Patents (323)
Patient recruitment (174)
Peanut (55)
People (65731)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (22941)
Phase II (32274)
Phase III (24301)
Pipeline (1706)
Policy (243)
Postmarket research (3552)
Preclinical (10360)
Press Release (72)
Prostate cancer (150)
Psychedelics (46)
Radiopharmaceuticals (279)
Rare diseases (529)
Real estate (7402)
Recruiting (76)
Regulatory (27188)
Reports (61)
Research institute (2666)
Resumes & cover letters (650)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (98)
Series A (173)
Series B (118)
Service/supplier (30)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (4305)
State (2)
Stomach cancer (17)
Supply chain (84)
Tariffs (65)
The Weekly (94)
Vaccines (919)
Venture capital (58)
Weight loss (332)
Women's health (52)
Worklife (20)
Date
Today (98)
Last 7 days (427)
Last 30 days (2062)
Last 365 days (34043)
2025 (18547)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1273)
Alabama (70)
Alaska (7)
Arizona (281)
Arkansas (14)
Asia (50544)
Australia (8878)
California (7813)
Canada (2420)
China (728)
Colorado (340)
Connecticut (349)
Delaware (205)
Europe (115954)
Florida (1160)
Georgia (264)
Hawaii (2)
Idaho (66)
Illinois (743)
India (33)
Indiana (386)
Iowa (19)
Japan (239)
Kansas (116)
Kentucky (33)
Louisiana (18)
Maine (73)
Maryland (1109)
Massachusetts (5976)
Michigan (276)
Minnesota (487)
Mississippi (3)
Missouri (101)
Montana (32)
Nebraska (26)
Nevada (83)
New Hampshire (73)
New Jersey (2192)
New Mexico (31)
New York (2191)
North Carolina (1250)
North Dakota (10)
Northern California (3366)
Ohio (253)
Oklahoma (17)
Oregon (48)
Pennsylvania (1666)
Puerto Rico (18)
Rhode Island (39)
South America (1654)
South Carolina (36)
South Dakota (1)
Southern California (2896)
Tennessee (129)
Texas (1198)
United States (29503)
Utah (231)
Virginia (215)
Washington D.C. (80)
Washington State (692)
West Virginia (4)
Wisconsin (86)
There are 853,008 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fortrea Announces Date for Second Quarter 2025 Financial Results and Conference Call
July 17, 2025
·
1 min read
Press Releases
Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach
July 17, 2025
·
8 min read
Press Releases
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - July 16, 2025
July 17, 2025
·
2 min read
Press Releases
Amphista Therapeutics announces achievement of a research milestone in its collaboration with Merck triggering a milestone payment
July 17, 2025
·
2 min read
Press Releases
Cognition Therapeutics’ Positive Clinical Data from Zervimesine (CT1812) Phase 2 Study in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at AAIC
July 17, 2025
·
10 min read
Press Releases
Jaya Biosciences Receives Patent Notices of Allowance in Japan, China, and Singapore for Novel Methods of Treating Neurological Diseases, including Alzheimer’s, Further Strengthening its Global Intellectual Property Portfolio
July 17, 2025
·
5 min read
Press Releases
CVRx Announces Positive News on Outpatient Payment for Barostim
July 17, 2025
·
3 min read
Press Releases
Zevra Therapeutics Announces Open Label Extension Data Showing Sustained Long-Term Efficacy of MIPLYFFA for the Treatment of NPC Published in the Journal of Molecular Genetics and Metabolism
July 17, 2025
·
7 min read
Press Releases
MolDX to Convene Expert Medical Panel on Medicare Local Coverage Determination (LCD) for Lucid Diagnostics’ EsoGuard® Esophageal DNA Test
July 17, 2025
·
4 min read
Press Releases
Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement
July 17, 2025
·
8 min read
1 of 85,301
Next
